US public and private reimbursers at odds over carotid stenting
This article was originally published in Clinica
Executive Summary
An influential US private sector health technology assessment group has decided not to endorse coverage of carotid artery angioplasty with stenting, putting it at odds with Medicare's own pending coverage decision.